Related Experiment Video

Updated: Mar 9, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.7K

The role of microRNAs in prethrombotic status associated with coronary artery disease

Jie Gao, Xiaojuan Ma, Ying Zhang

  • 1Prof. Dazhuo Shi, Department of Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing100091, People's Republic of China, Tel.: +86 15010355963,

Thrombosis and Haemostasis
|December 23, 2016
PubMed

Insights

MicroRNAs (miRNAs) show promise in identifying a prethrombotic status, an imbalance leading to cardiovascular events in coronary artery disease (CAD). Further research into these small RNAs could lead to new diagnostic biomarkers and treatments for CAD patients.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Biochemistry

Background:

  • Acute cardiovascular events, often fatal in coronary artery disease (CAD) patients, are linked to thrombus formation.
  • A prethrombotic status, characterized by imbalanced procoagulant and anticoagulant conditions, precedes thrombogenesis and increases cardiovascular risk.
  • Current diagnostic methods lack a gold standard for identifying prethrombotic status, hindering early intervention.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in the pathophysiology of prethrombotic status.
  • To explore the potential of differentially expressed miRNAs in coronary artery disease (CAD) as diagnostic biomarkers.
  • To discuss the therapeutic implications of miRNAs for managing CAD and preventing cardiovascular events.

Main Methods:

  • Literature review focusing on the involvement of miRNAs in key processes of prethrombotic status.
  • Analysis of studies reporting altered miRNA expression in patients with coronary artery disease (CAD).
  • Synthesis of current understanding regarding miRNA-mediated gene regulation in thrombogenesis.

Main Results:

  • MicroRNAs (miRNAs) are implicated in endothelial dysfunction, platelet activation, fibrinolysis, and coagulation factor regulation, all relevant to prethrombotic status.
  • Specific miRNAs exhibit altered expression patterns in coronary artery disease (CAD) patients, suggesting their involvement in the disease's prethrombotic state.
  • miRNAs offer a fine-tuned regulatory mechanism influencing multiple aspects of the prethrombotic condition.

Conclusions:

  • MicroRNAs (miRNAs) represent a novel class of molecules involved in the development of prethrombotic status.
  • Differentially expressed miRNAs in coronary artery disease (CAD) hold potential as diagnostic biomarkers for early detection.
  • Targeting specific miRNAs may offer innovative therapeutic strategies for CAD patients at risk of thrombotic events.

Keywords:
MicroRNAsbiomarkerscoronary artery diseaseprethrombotic status

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
857
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
597